Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar injury and regeneration following deletion of ABCA3
Tara N. Rindler, Courtney A. Stockman, Alyssa L. Filuta, Kari M. Brown, John M. Snowball, Wenjia Zhou, Ruud Veldhuizen, Erika M. Zink, Sydney E. Dautel, Geremy Clair, Charles Ansong, Yan Xu, James P. Bridges, Jeffrey A. Whitsett
Tara N. Rindler, Courtney A. Stockman, Alyssa L. Filuta, Kari M. Brown, John M. Snowball, Wenjia Zhou, Ruud Veldhuizen, Erika M. Zink, Sydney E. Dautel, Geremy Clair, Charles Ansong, Yan Xu, James P. Bridges, Jeffrey A. Whitsett
View: Text | PDF
Research Article Pulmonology

Alveolar injury and regeneration following deletion of ABCA3

  • Text
  • PDF
Abstract

Adaptation to air breathing after birth is dependent upon the synthesis and secretion of pulmonary surfactant by alveolar type 2 (AT2) cells. Surfactant, a complex mixture of phospholipids and proteins, is secreted into the alveolus, where it reduces collapsing forces at the air-liquid interface to maintain lung volumes during the ventilatory cycle. ABCA3, an ATP-dependent Walker domain containing transport protein, is required for surfactant synthesis and lung function at birth. Mutations in ABCA3 cause severe surfactant deficiency and respiratory failure in newborn infants. We conditionally deleted the Abca3 gene in AT2 cells in the mature mouse lung. Loss of ABCA3 caused alveolar cell injury and respiratory failure. ABCA3-related lung dysfunction was associated with surfactant deficiency, inflammation, and alveolar-capillary leak. Extensive but incomplete deletion of ABCA3 caused alveolar injury and inflammation, and it initiated proliferation of progenitor cells, restoring ABCA3 expression, lung structure, and function. M2-like macrophages were recruited to sites of AT2 cell proliferation during the regenerative process and were present in lung tissue from patients with severe lung disease caused by mutations in ABCA3. The remarkable and selective regeneration of ABCA3-sufficient AT2 progenitor cells provides plausible approaches for future correction of ABCA3 and other genetic disorders associated with surfactant deficiency and acute interstitial lung disease.

Authors

Tara N. Rindler, Courtney A. Stockman, Alyssa L. Filuta, Kari M. Brown, John M. Snowball, Wenjia Zhou, Ruud Veldhuizen, Erika M. Zink, Sydney E. Dautel, Geremy Clair, Charles Ansong, Yan Xu, James P. Bridges, Jeffrey A. Whitsett

×

Figure 6

Proliferation of alveolar cells following partial deletion of Abca3.

Options: View larger image (or click on image) Download as PowerPoint
Proliferation of alveolar cells following partial deletion of Abca3.
(A)...
(A) Total cell proliferation was quantitated using Nikon Elements General Analysis software in control and Abca3-cKO mice treated with tamoxifen for 4 days as a proportion of DAPI+ cells. (B) At the peak of proliferation (2 weeks), BrdU+ cells were classified as ECAD+, SOX17+, or CD45+. BrdU+ cells were classified as proximal epithelium (NKX2.1+SOX2+ or NKX2.1–SOX2+) or distal epithelium (NKX2.1+SOX2–) (C), or as AT1 epithelial cells (NKX2.1+HOPX+) or AT2 epithelial cells (NKX2+proSPC+) (D). Proliferating AT2 cells were further defined as ABCA3+ or ABCA3– (E). Data represent mean ± SEM, n = 3–4/group, *P < 0.05 as determined by 1-way ANOVA and **P ≤ 0.01, ***P = 0.0001, and ****P < 0.0001 as determined by 2-tailed Student’s t test. (F) Diagram summarizing proliferating cell types in Abca3-cKO mice. Percentages of proliferating (BrdU+) cells are shown, with data from graphs outlined in blue. Representative images used for quantitation are shown in Figure 7.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts